AtaiBeckley (ATAI) Return on Invested Capital (2021 - 2025)
AtaiBeckley (ATAI) reported Return on Invested Capital of 0.06% for Q3 2025, down 4.0% on a YoY basis from 0.06% in Q3 2024, and down 5.7% sequentially from 0.05% in Q2 2025.
AtaiBeckley (ATAI) Return on Invested Capital (2021 - 2025) Analysis & Trends
AtaiBeckley (ATAI) has 5 years of Return on Invested Capital data on file, last reported at 0.06% in Q3 2025.
- For the quarter ending Q3 2025, Return on Invested Capital fell 4.0% year-over-year to 0.06%; the trailing twelve-month figure through Sep 2025 stood at 0.06% (down 4.0% YoY), and the FY2024 full-year result was 0.31%, changed N/A from the prior year.
- Return on Invested Capital slipped to 0.06% in Q3 2025, from 0.05% in the prior quarter.
- In the past five years, Return on Invested Capital ranged from a high of 0.01% in Q1 2024 to a low of 30.8% in Q3 2021.
- A 5-year average of 4.24% and a median of 0.02% in 2022 frame the typical range for Return on Invested Capital.
- Across the five-year window, Return on Invested Capital jumped 3078 bps in 2022 and retreated 25 bps in 2024, its largest moves.
- Tracing ATAI's Return on Invested Capital over 5 years: stood at 13.36% in 2021, then jumped by 100 bps to 0.01% in 2022, then soared by 35 bps to 0.01% in 2023, then plunged by 4196 bps to 0.25% in 2024, then surged by 77 bps to 0.06% in 2025.
- Business Quant data shows ATAI's Return on Invested Capital at 0.06% in Q3 2025, 0.05% in Q2 2025, and 0.08% in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.00% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.04% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | AtaiBeckley | 2.56 Bn | 2.56 Bn | - | -0.06% |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -0.06% |
| Jun 30, 2025 | -0.05% |
| Mar 31, 2025 | -0.08% |
| Dec 31, 2024 | -0.25% |
| Sep 30, 2024 | -0.02% |
| Jun 30, 2024 | -0.01% |
| Mar 31, 2024 | -0.01% |
| Dec 31, 2023 | -0.01% |
| Sep 30, 2023 | -0.01% |
| Jun 30, 2023 | -0.01% |
| Mar 31, 2023 | -0.01% |
| Dec 31, 2022 | -0.01% |
| Sep 30, 2022 | -0.02% |
| Jun 30, 2022 | -13.70% |
| Mar 31, 2022 | -13.63% |
| Dec 31, 2021 | -13.36% |
| Sep 30, 2021 | -30.80% |